COVID-19-associated thyroid diseases: Difference between revisions
Jump to navigation
Jump to search
| Line 24: | Line 24: | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for [COVID-19-associated thyroid diseases]. | |||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== | ||
Revision as of 14:14, 14 July 2022
Template:COVID-19 thyroid disorders
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
COVID-19 has been found to affect several organs and body systems, including the endocrine system, with short-term and possible long-term consequences.
Historical Perspective
Classification
There is no established system for the classification of COVID-19-associated thyroid disorders.
Pathophysiology
Causes
Differentiating ((Page name)) from other Diseases
Epidemiology and Demographics
Risk Factors
There are no established risk factors for COVID-19-associated thyroid diseases.
Screening
There is insufficient evidence to recommend routine screening for [COVID-19-associated thyroid diseases].